Kymera Therapeutics, Inc. · NASDAQ:KYMR

Jacobs Bruce N. exercised options for 15,000 Kymera Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 19, 2026

On May 18, 2026, Jacobs Bruce N. (Chief Financial Officer) exercised options for 15,000 Kymera Therapeutics, Inc. shares at US$2.08 for US$31,200, leaving 247,588 shares. Filed May 19, 2026 (Form 4).

Options exercised
15,000 shares
Price
US$2.08
Value
US$31,200
Holding after
247,588 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockOption exercise15,000US$2.08247,588Direct

Source

View original at SEC

Related